Pfizer Inc. and Clear Creek Bio Inc. on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline.
https://www.pharmalive.com/wp-content/uploads/2022/02/U.S.-plans-to-roll-out-COVID-19-shots-for-children-under-5-years-in-February-Reuters-2-10-22.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-12-06 08:45:052022-12-06 09:47:11Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug
